Molecular Cancer (Oct 2024)
Correction: Nac1 promotes stemness and regulates myeloid‑derived cell status in triple‑negative breast cancer
- Chrispus Ngule,
- Ruyi Shi,
- Xingcong Ren,
- Hongyan Jia,
- Felix Oyelami,
- Dong Li,
- Younhee Park,
- Jinhwan Kim,
- Hami Hemati,
- Yi Zhang,
- Xiaofang Xiong,
- Andrew Shinkle,
- Nathan L. Vanderford,
- Sara Bachert,
- Binhua P. Zhou,
- Jianlong Wang,
- Jianxun Song,
- Xia Liu,
- Jin‑Ming Yang
Affiliations
- Chrispus Ngule
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Ruyi Shi
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Xingcong Ren
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Hongyan Jia
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Felix Oyelami
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Dong Li
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Younhee Park
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Jinhwan Kim
- Department of Biochemistry, and Markey Cancer Center, University of Kentucky College of Medicine
- Hami Hemati
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Yi Zhang
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Xiaofang Xiong
- Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center
- Andrew Shinkle
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Nathan L. Vanderford
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Sara Bachert
- Department of Pathology and Laboratory Medicine, University of Kentucky
- Binhua P. Zhou
- Department of Biochemistry, and Markey Cancer Center, University of Kentucky College of Medicine
- Jianlong Wang
- Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center
- Jianxun Song
- Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center
- Xia Liu
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- Jin‑Ming Yang
- Department of Toxicology and Cancer Biology, Department of Pharmacology and Nutritional Science, and Markey Cancer Center, University of Kentucky College of Medicine
- DOI
- https://doi.org/10.1186/s12943-024-02143-3
- Journal volume & issue
-
Vol. 23,
no. 1
pp. 1 – 4
Abstract
No abstracts available.
